{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:53Z","timestamp":1761128573184},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/s11926-002-0082-1","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T16:03:52Z","timestamp":1180800232000},"page":"387-391","source":"Crossref","is-referenced-by-count":9,"title":["Antiphospholipid antibodies in pediatrics"],"prefix":"10.1007","volume":"4","author":[{"given":"Ana I.","family":"Quintero-Del-Rio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"82_CR1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999, 42:1309\u20131311.","journal-title":"Arthritis Rheum"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002281-199909000-00010","volume":"11","author":"T Arkachaisri","year":"1999","unstructured":"Arkachaisri T, Lehman TJA: Systemic lupus erythematosus and related disorders of childhood. Curr Opin Rheumatol 1999, 11:384\u2013392.","journal-title":"Curr Opin Rheumatol"},{"key":"82_CR3","first-page":"235","volume":"98","author":"N Venkat-Raman","year":"2001","unstructured":"Venkat-Raman N, Backos M, Teoh TG, et al.: Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001, 98:235\u2013242.","journal-title":"Obstet Gynecol"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2000-13733","volume":"18","author":"RM Lee","year":"2000","unstructured":"Lee RM, Silver RM: Recurrent pregnancy loss: summary and clinical recommendations. Semin Reproc Med 2000, 18:433\u2013440.","journal-title":"Semin Reproc Med"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(00)00404-8","volume":"96","author":"D Vinatier","year":"2001","unstructured":"Vinatier D, Dufour P, Cosson M, Houpeau JL: Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001, 96:37\u201350. The article reviews in detail all the aspects of antiphospholipid antibodies during pregnancy, such as pathophysiology and treatments.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"82_CR6","first-page":"394","volume":"97","author":"H Masamoto","year":"2001","unstructured":"Masamoto H, Toma T, Sakumoto K, Kanazawa K: Clearance of antiphospholipid antibodies in pregnancies treated with heparin. Obstet Gynecol 2001, 97:394\u2013398.","journal-title":"Obstet Gynecol"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/humrep\/15.5.1170","volume":"15","author":"SB Cohen","year":"2000","unstructured":"Cohen SB, Goldenberg M, Rabinovici J, et al.: Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. Hum Reprod 2000, 15:1170\u20131172.","journal-title":"Hum Reprod"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1471-0528.1999.tb08208.x","volume":"106","author":"M Backos","year":"1999","unstructured":"Backos M, Rai R, Baxter N, et al.: Pregnancy complications in woman with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999, 106:102\u2013107.","journal-title":"Br J Obstet Gynaecol"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00003081-200103000-00002","volume":"44","author":"G William","year":"2001","unstructured":"William G, Branch W: Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet Gynecol 2001, 44:2\u201310.","journal-title":"Clin Obstet Gynecol"},{"key":"82_CR10","first-page":"914","volume":"119","author":"LP Noel","year":"2001","unstructured":"Noel LP, Botash AS, DeSilva A: Maternal antiphospholipid antibodies and vitreous hemorrhage in the newborn: a case report. Arch Ophtalmol 2001, 119:914\u2013916.","journal-title":"Arch Ophtalmol"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/JPM.1999.025","volume":"27","author":"JA Brewster","year":"1999","unstructured":"Brewster JA, Shaw NJ, Farquharson RG: Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999, 27:183\u2013187.","journal-title":"J Perinat Med"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0049-3848(99)00241-8","volume":"98","author":"HJG Siemens","year":"2000","unstructured":"Siemens HJG, Gutsche S, Br\u00fcckner S, et al.: Antiphospholipid antibodies in children without and in adults with or without thrombophilia. Thromb Res 2000, 98:241\u2013247.","journal-title":"Thromb Res"},{"key":"82_CR13","first-page":"370","volume":"28","author":"EA Higginbothan","year":"2001","unstructured":"Higginbothan EA, Zimmerman SA, Howard TA, et al.: Effects of inherited thrombophilic mutations in an adolescent with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2001, 28:370\u2013372.","journal-title":"J Rheumatol"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/47.9.1597","volume":"47","author":"A Tripodi","year":"2001","unstructured":"Tripodi A, Mannuccio PM: Laboratory investigation of thrombophilia. Clin Chem 2001, 47:1597\u20131606.","journal-title":"Clin Chem"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.STR.31.6.1283","volume":"31","author":"G Kenet","year":"2000","unstructured":"Kenet G, Sadetzki S, Murad H, et al.: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000, 31:1283\u20131288. The authors present the prevalence of thrombophilic markers in children with and without history of thrombotic events.","journal-title":"Stroke"},{"key":"82_CR16","first-page":"62","volume":"99","author":"HC Wang","year":"2000","unstructured":"Wang HC, Tu HC, Choi WM: Ischemic stroke in a teenage girl with primary antiphospholipid antibody syndrome. J Formos Med Assoc 2000, 99:62\u201365.","journal-title":"J Formos Med Assoc"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/03009749950155535","volume":"28","author":"EB Nordal","year":"1999","unstructured":"Nordal EB, Nielsen J, Marhaug G: Chorea in juvenile primary antiphospholipid syndrome. Scand J Rheumatol 1999, 28:324\u2013327.","journal-title":"Scand J Rheumatol"},{"key":"82_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/BF02731061","volume":"65","author":"A Kakar","year":"1998","unstructured":"Kakar A, Sethi PK: Primary antiphospholipid syndrome in stroke in the young. Indian J Pediatr 1998, 65:757\u2013760.","journal-title":"Indian J Pediatr"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00007611-200093110-00018","volume":"93","author":"J Kreikemeier","year":"2000","unstructured":"Kreikemeier J, Tobias JD: Antiphospholipid antibody syndrome manifested as a postoperative cerebrovascular event in a child. South Med J 2000, 93:1115\u20131119.","journal-title":"South Med J"},{"key":"82_CR20","first-page":"527","volume":"49","author":"K Singh","year":"2001","unstructured":"Singh K, Gaiha M, Shome DK, et al.: The association of antiphospholipid antibodies with ischaemic stroke and myocardial infarction in young and their correlation: a preliminary study. J Assoc Physicians India 2001, 49:527\u2013529.","journal-title":"J Assoc Physicians India"},{"key":"82_CR21","first-page":"1274","volume":"37","author":"KS Agarwal","year":"2000","unstructured":"Agarwal KS, Puliyel JM, Khanduri U: Sudden onset profound deafness in association with antiphospholipid antibodies in a child with SLE. Indian Pediatr 2000, 37:1274\u20131275.","journal-title":"Indian Pediatr"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/ocii.9.1.49.3980","volume":"9","author":"D Giorgi","year":"2001","unstructured":"Giorgi D, David V, Afeltra A, Gabrieli CB: Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome. Ocul Immunol Inflamm 2001, 9:49\u201357.","journal-title":"Ocul Immunol Inflamm"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000046236","volume":"21","author":"R Sinniah","year":"2001","unstructured":"Sinniah R, Gan HC, Yoon KH: Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis. Am J Nephrol 2001, 21:134\u2013140.","journal-title":"Am J Nephrol"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/rheumatology\/40.8.863","volume":"40","author":"KE Moss","year":"2001","unstructured":"Moss KE, Isenberg DA: Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus and SLE alone. Rheumatology 2001, 40:863\u2013867.","journal-title":"Rheumatology"},{"key":"82_CR25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jpsu.2001.22315","volume":"36","author":"M Yasutomi","year":"2001","unstructured":"Yasutomi M, Egawa H, Kobayashi Y, et al.: Living donor liver transplantation for Budd-Chiari syndrome with inferior vena cava obstruction and association antiphospholipid antibody syndrome. J Pediatr Surg 2001, 36:659\u2013662.","journal-title":"J Pediatr Surg"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1440-1754.2001.00673.x","volume":"37","author":"SF Yuen","year":"2001","unstructured":"Yuen SF, Lau KF, Steinberg AW, et al.: Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus. J Paediatr Child Health 2001, 37:405\u2013408.","journal-title":"J Paediatr Child Health"},{"key":"82_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s004310050052","volume":"159","author":"M Gattorno","year":"2000","unstructured":"Gattorno M, Molinari AC, Buoncompagni A, et al.: Recurrent antiphospholipid-related deep vein thrombosis as presenting manifestation of systemic lupus erythematosus. Eur J Pediatr 2000, 159:211\u2013214.","journal-title":"Eur J Pediatr"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/ndt\/15.11.1891","volume":"15","author":"MS Faria","year":"2000","unstructured":"Faria MS, Mota C, Barbot J, et al.: Haemolytic uraemic s\u00edndrome, cardiomyopathy, cutaneous vasculopathy and antiphospholipid activity. Nephrol Dial Transplant 2000, 15:1891\u20131892.","journal-title":"Nephrol Dial Transplant"},{"key":"82_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002281-199909000-00010","volume":"11","author":"T Arkachaisri","year":"1999","unstructured":"Arkachaisri T, Lehman TJA: Systemic lupus erythematosus and related disorders of childhood. Curr Opin Rheumatol 1999, 11:384\u2013392. This article reviews the pathogenesis and related disorder in children with lupus.","journal-title":"Curr Opin Rheumatol"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2249.2000.01206.x","volume":"120","author":"M Sorice","year":"2000","unstructured":"Sorice M, Pittoni V, Griggi T, et al.: Specificity of antiphospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol 2000, 120:301\u2013306.","journal-title":"Clin Exp Immunol"},{"key":"82_CR31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002281-200109000-00013","volume":"13","author":"T Lee","year":"2001","unstructured":"Lee T, Scheven EV, Sandborg C: Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 2001, 13:415\u2013421.","journal-title":"Curr Opin Rheumatol"},{"key":"82_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00003081-200103000-00007","volume":"44","author":"SS Pierangeli","year":"2001","unstructured":"Pierangeli SS, Gharavi AE, Harris EN: Testing for antiphospholipid antibodies: problems and solutions. Clin Obstet Gynecol 2001, 44:48\u201357.","journal-title":"Clin Obstet Gynecol"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-857X(05)70218-0","volume":"27","author":"JT Merrill","year":"2001","unstructured":"Merrill JT: Which antiphospholipid antibody tests are most useful? Rheum Dis Clin North Am 2001, 27:525\u2013549.","journal-title":"Rheum Dis Clin North Am"},{"key":"82_CR34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/rheumatology\/40.9.1026","volume":"40","author":"M Samarkos","year":"2001","unstructured":"Samarkos M, Davies KA, Gordon C, et al.: IgG subclass distribution of antibodies against \u00e22-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations. Rheumatology 2001, 40:1026\u20131032.","journal-title":"Rheumatology"},{"key":"82_CR35","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2","volume":"43","author":"T Atsumi","year":"2000","unstructured":"Atsumi T, Ieko M, Bertolaccini ML, et al.: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000, 43:1982\u20131993.","journal-title":"Arthritis Rheum"},{"key":"82_CR36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1098-2825(2000)14:3<87::AID-JCLA1>3.0.CO;2-O","volume":"14","author":"E Rapizzi","year":"2000","unstructured":"Rapizzi E, Ruffatti A, Tonello M, et al.: Correction of age of anticardiolipin antibodies cut-off points. J Clin Lab Anal 2000, 14:87\u201390.","journal-title":"J Clin Lab Anal"},{"key":"82_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","volume":"40","author":"T Avein","year":"2001","unstructured":"Avein T, Ambrozic A, Kuhar M, et al.: Anticardiolipin and anti- \u03b22 glycoprotein 1 antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001, 40:565\u2013573.","journal-title":"Rheumatology"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00003081-200103000-00004","volume":"44","author":"S Esplin","year":"2001","unstructured":"Esplin S: Management of antiphospholipid syndrome during pregnancy. Clin Obstet Gynecol 2001, 44:20\u201328.","journal-title":"Clin Obstet Gynecol"},{"key":"82_CR39","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","volume":"44","author":"D Erkan","year":"2001","unstructured":"Erkan D, Merrill JT, Yazici Y, et al.: High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001, 44:1466\u20131467.","journal-title":"Arthritis Rheum"},{"key":"82_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1191\/096120301667789546","volume":"10","author":"G Ruiz-Irastorza","year":"2001","unstructured":"Ruiz-Irastorza G, Khamashta MA, Hughes GRV: Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes\u2019 syndrome. Lupus 2001, 10:241\u2013245.","journal-title":"Lupus"},{"key":"82_CR41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"W Branch","year":"2000","unstructured":"Branch W, Peaceman AM, Druzin M, et al.: A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000, 182:122\u2013127.","journal-title":"Am J Obstet Gynecol"},{"key":"82_CR42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/1529-0131(200104)44:4<876::AID-ANR144>3.0.CO;2-2","volume":"44","author":"SS Pierangeli","year":"2000","unstructured":"Pierangeli SS, Espinola R, Liu X, et al.: Identification of an Fc [gamma] receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum 2000, 44:876\u2013883.","journal-title":"Arthritis Rheum"},{"key":"82_CR43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(00)04239-2","volume":"357","author":"G Ruiz-Irastorza","year":"2001","unstructured":"Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV: Systemic lupus erythematosus. Lancet 2001, 357:1027\u20131032.","journal-title":"Lancet"},{"key":"82_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-857X(05)70225-8","volume":"27","author":"M Petri","year":"2001","unstructured":"Petri M: Antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am 2001, 27:633\u2013642.","journal-title":"Rheum Dis Clin North Am"},{"key":"82_CR45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/096120339900800614","volume":"8","author":"E Cr\u00e9tel","year":"1999","unstructured":"Cr\u00e9tel E, Cacoub P, Huong DLT, et al.: Massive ovarian hemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases. Lupus 1999, 8:482\u2013485.","journal-title":"Lupus"},{"key":"82_CR46","first-page":"238","volume":"27","author":"J Rojas-Rodriguez","year":"2000","unstructured":"Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M, et al.: Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 2000, 27:238\u2013240.","journal-title":"J Rheumatol"},{"key":"82_CR47","first-page":"20","volume":"27","author":"BL Myones","year":"2000","unstructured":"Myones BL, McCurdy D: The antiphospholipid syndrome: immunologic and clinical aspects: clinical spectrum and treatment. J Rheumatol 2000, 27:20\u201328.","journal-title":"J Rheumatol"},{"key":"82_CR48","doi-asserted-by":"crossref","unstructured":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (Porter TF, Silver RM, Branch DWPEP) trial. Lancet 2000, 355:1295\u20131302.","DOI":"10.1016\/S0140-6736(00)02110-3"},{"key":"82_CR49","first-page":"41","volume":"32","author":"G Valesini","year":"2000","unstructured":"Valesini G, Pittoni V: Treatment of thrombosis associated with immunological risk factors. Ann Med 2000, 32:41\u201345.","journal-title":"Ann Med"},{"key":"82_CR50","first-page":"2817","volume":"27","author":"D Erkan","year":"2000","unstructured":"Erkan D, Yazici Y, Sobel R, Lockshin MD: Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000, 27:2817\u20132821.","journal-title":"J Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-002-0082-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0082-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:19:12Z","timestamp":1587575952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-002-0082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11926-002-0082-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}